Anastrozole (Page 9 of 9)

16 HOW SUPPLIED/STORAGE AND HANDLING

Anastrozole tablets, USP 1 mg are white to off-white, round biconvex, film coated tablets, with “AHI” debossing on one side and plain on other side and are supplied as follows:

Bottle of 30 tablets, NDC 0904-6195-46

Storage

Store at controlled room temperature, 20 to 25°C (68 to 77°F) [see USP]. Preserve in tight container.

17 PATIENT COUNSELING INFORMATION

“See FDA approved patient labeling (Patient Information).”

Hypersensitivity Reactions

Inform patients of the possibility of serious allergic reactions with swelling of the face, lips, tongue and/or throat (angioedema) which may cause difficulty in swallowing and/or breathing and to seek medical attention immediately [see Contraindications (4)] .

Ischemic Cardiovascular Events

Patients with pre-existing ischemic heart disease should be informed that an increased incidence of cardiovascular events has been observed with anastrozole use compared to tamoxifen use. Advise patients if new or worsening chest pain or shortness of breath occurs to seek medical attention immediately [see Warnings and Precautions (5.1)] .

Bone Effects

Inform patients that anastrozole lowers the level of estrogen. This may lead to a loss of the mineral content of bones, which might decrease bone strength. A possible consequence of decreased mineral content of bones is an increase in the risk of fractures [see Warnings and Precautions (5.2)] .

Cholesterol

Inform patients that an increased level of cholesterol might be seen while receiving anastrozole [see Warnings and Precautions (5.3)] .

Carpal Tunnel

Patients should be informed that if they experience tickling, tingling, or numbness they should notify their health care provider [see Adverse Reactions (6.1)] .

Tamoxifen

Patients should be advised not to take anastrozole with Tamoxifen [see Clinical Studies (14.1)] .

Missed Doses

Inform patients that if they miss a dose, take it as soon as they remember. If it is almost time for their next dose, skip the missed dose and take the next regularly scheduled dose. Patients should not take two doses at the same time.

Embryo-Fetal Toxicity

Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception during ARIMIDEX therapy and for at least 3 weeks after the last dose. Advise females to contact their healthcare provider if they become pregnant, or if pregnancy is suspected, during treatment with anastrozole [see Warning and Precautions (5.4) and Use in Specific Populations ( 8.1, 8.3)] .

Lactation

Advise women not to breastfeed during anastrozole treatment and for at least 2 weeks after the last dose [see Use in Specific Population (8.2)] .

Manufactured For:

Accord Healthcare, Inc.,
1009 Slater Road,
Suite 210-B,
Durham, NC 27703,
USA.

Manufactured By:

Intas Pharmaceuticals Limited,
Ahmedabad – 380 054, INDIA.

Distributed By:

MAJOR® PHARMACEUTICALS

17177 N Laurel Park Dr., Suite 233

Livonia, MI 48152

10 2311 0 677194

Issued February 2019

Patient Information

Anastrozole Tablets
(an as’ troe zole)

What is the most important information I should know about anastrozole tablet? Anastrozole tablets may cause serious side effects including:

heart disease. Women with early breast cancer, who have a history of blockage in their heart arteries (ischemic heart disease) and who take anastrozole tablets, may have an increase in symptoms of decreased blood flow to their heart compared to similar women who take tamoxifen.

Get medical help right away if you have new or worsening chest pain or shortness of breath during treatment with anastrozole tablets.

What is anastrozole tablet?

Anastrozole tablet is a prescription medicine used in women after menopause (“the change of life”) for:

treatment of early breast cancer
after surgery
in women whose breast cancer is hormone receptor-positive
the first treatment of breast cancer that has spread to nearby tissue or lymph nodes (locally advanced) or has spread to other parts of the body (metastatic), in women whose breast cancer is hormone receptor-positive or the hormone receptors are not known
treatment of advanced breast cancer, if the cancer has grown, or the disease has spread after tamoxifen therapy.

Anastrozole tablet does not work in women with breast cancer who have not gone through menopause (premenopausal women).

Who should not take anastrozole tablets?

Do not take anastrozole tablet if you:

have had a severe allergic reaction to anastrozole or any of the ingredients in anastrozole tablets. See the end of this leaflet for a complete list of ingredients in anastrozole tablets. Symptoms of a severe allergic reaction to anastrozole tablets include: swelling of the face, lips, tongue, or throat, trouble breathing or swallowing, hives and itching.

What should I tell my healthcare provider before taking anastrozole tablets?

Before you take anastrozole tablets, tell your healthcare provider if you:

are still having menstrual periods (are not past menopause). Talk to your healthcare provider if you are not sure.
have or had a heart problem
have been told you have bone thinning or weakness (osteoporosis)
have high cholesterol
have any other medical conditions
are pregnant or plan to become pregnant. Taking anastrozole tablet during pregnancy or within 3 weeks of becoming pregnant may harm your unborn baby.
Females who are able to become pregnant should have a pregnancy test before starting treatment with anastrozole tablets.
Females who are able to become pregnant should use effective birth control (contraceptive) during treatment with anastrozole tablets and for 3 weeks after your last dose of anastrozole tablets. Tell your healthcare provider right away if you become pregnant or think you may be pregnant.
are breastfeeding or plan to breastfeed. It is not known if anastrozole passes into breast milk. Do not breastfeed during treatment with anastrozole tablets and for 2 weeks after your last dose of anastrozole tablets.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take:

tamoxifen. You should not take anastrozole tablets if you take tamoxifen. Taking anastrozole tablets with tamoxifen may lower the amount of anastrozole in your blood and may cause anastrozole tablets not to work as well.
Medicines that contain estrogen. Anastrozole tablet may not work if taken with any of these medicines:
hormone replacement therapy
birth control pills
estrogen creams
vaginal rings
vaginal suppositories

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take anastrozole tablets?

Take anastrozole tablets exactly as your healthcare provider tells you to take it.
Continue taking anastrozole tablets until your healthcare provider tells you to stop.
Anastrozole tablets can be taken with or without food.
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Take your next regularly scheduled dose. Do not take two doses at the same time.

If you take too much anastrozole tablets, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of anastrozole tablets?

Anastrozole tablets may cause serious side effects including:

See “ What is the most important information I should know about anastrozole tablet ?”
bone thinning or weakness (osteoporosis). Anastrozole lowers estrogen in your body, which may cause your bones to become thinner and weaker. This may increase your risk of fractures, especially of your spine, hip and wrist. Your healthcare provider may order a bone mineral density test before you start and during treatment with anastrozole tablets to check you for bone changes.
increased blood cholesterol (fat in the blood). Your healthcare provider may do blood tests to check your cholesterol while you are taking anastrozole tablets.
skin reactions. Stop taking anastrozole tablets and call your healthcare provider right away if you get any skin lesions, ulcers, or blisters.
severe allergic reactions. Get medical help right away if you get:
swelling of your face, lips, tongue, or throat.
trouble swallowing or breathing
liver problems. Anastrozole can cause inflammation of your liver and changes in liver function blood tests. Your healthcare provider may check you for this.
Stop taking anastrozole tablets and call your healthcare provider right away if you have any of these signs or symptoms of a liver problem:
a general feeling of not being well
yellowing of your skin or whites of your eyes
pain on the right side of your stomach-area (abdomen)

Common side effects in women taking anastrozole tablets include:

hot flashes
weakness
joint aches
joint pain, stiffness or swelling (arthritis)
pain
sore throat
high blood pressure
depression
nausea and vomiting
rash
back pain
sleep problems
bone pain
headache
swelling of your legs, ankles, or feet
increased cough
shortness of breath
build up of lymph fluid in the tissues of your affected arm (lymphedema)

Anastrozole tablets may also cause you to have tickling, tingling or numbness of your skin.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of anastrozole tablets. For more information, ask your healthcare provider or pharmacist.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store anastrozole tablets?

Store anastrozole tablets at room temperature between 68°F to 77°F (20°C to 25°C). Preserve in tight container.
Keep anastrozole tablets and all medicines out of the reach of children.

General information about the safe and effective use of anastrozole tablets.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not take anastrozole tablets for a condition for which it was not prescribed. Do not give anastrozole tablets to other people, even if they have the same symptoms that you have. It may harm them.

If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about anastrozole tablets that is written for health professionals.

For more information, visit www.accordhealthcare.us or call Accord Healthcare Inc. at 1-866-941-7875.

What are the ingredients in anastrozole tablets?

Active ingredient: anastrozole

Inactive ingredients: lactose monohydrate, magnesium stearate, hypromellose, macrogol, povidone, sodium starch glycolate, and titanium dioxide.

This Patient Information has been approved by the U.S. Food and Drug Administration.

Manufactured For:

Accord Healthcare, Inc.,
1009 Slater Road,
Suite 210-B,
Durham, NC 27703,
USA.

Manufactured By:

Intas Pharmaceuticals Limited, Ahmedabad – 380 054, INDIA.

Distributed By:

MAJOR® PHARMACEUTICALS

17177 N Laurel Park Dr., Suite 233

Livonia, MI 48152

10 2311 0 677194

Issued February 2019

Anastrozole Tablets USP

1 mg

30 Tablets

bottle label
(click image for full-size original)
ANASTROZOLE anastrozole tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0904-6195(NDC:16729-035)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ANASTROZOLE (ANASTROZOLE) ANASTROZOLE 1 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
HYPROMELLOSE, UNSPECIFIED
POLYETHYLENE GLYCOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
SODIUM STARCH GLYCOLATE TYPE A POTATO
TITANIUM DIOXIDE
Product Characteristics
Color WHITE Score no score
Shape ROUND (round biconvex) Size 6mm
Flavor Imprint Code AHI
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0904-6195-46 30 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090568 06/15/2010
Labeler — Major Pharmaceuticals (191427277)
Registrant — Major Pharmaceuticals (191427277)

Revised: 10/2019 Major Pharmaceuticals

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.